Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2' Fluoro Deoxyribonucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115851694A details a novel immobilized enzyme method for synthesizing 2'-fluoro-deoxyribonucleosides, offering superior stability, reusability, and cost-effective manufacturing for antiviral intermediates.